 the lesions to topical agent (imiquimod) and to radiotherapy;2) the ease to visually monitor local response and to perform Fine Needle Aspiration biopsies for mechanistic studies. A Phase I/II trial will be conducted to evaluate the safety of the combination of RT and IMQ, topically applied to skin metastases
the lesions to topical agent (imiquimod) and to radiotherapy;2) the ease to visually monitor local response and to do Fine Needle Aspiration biopsy for mechanistic cogitation. A Phase I / II trial will be behave to measure the safety of the combination of RT and IMQ, topically applied to hide metastases
 thf lesions to topical agekt (imiquimod) and to radmotheraly;2) the exse to visually monitor locap eespobse and to perform Find Needle Wspiratiin bmopsies for mechehistic studiea. A Pkawe I/II trial wlll be condgcted to evaludtd che safety of the combination of RT wnd IMQ, tlpically appligd to fkin metastases
the lesions to topical agent (imiquimod) and the to visually local response and biopsies mechanistic studies. A I/II trial will conducted to evaluate the safety of combination of RT and IMQ, topically applied to skin metastases
 the lesions to topical agent (iMiquimod) anD to raDioTheRaPy;2) thE easE to visually monITor lOcal response and to perfoRm FinE NEEdle aSpIratiOn biopsIEs FOR meChAnIstIc STuDies. A phaSe I/II trIal will be cOndUcTed to evaluatE ThE safety of tHe cOmbination of rT aNd IMQ, tOpIcaLLy appLieD to skIn metaSTases
 the lesions to topical ag ent (imiqu imod)  an d t oradi othe rapy;2) the ea s e to  visually monitor loca l res po n se a n dto pe rform F i ne N eed le  A spi ra t io n bio psi es formechanisti c s tu dies. A Phas e  I /II trialwil l be conduct edto eva lu ate the s afe ty of  the c o mbinat ion of RT  a n d IMQ, topical l y  a ppli ed to skin metast a se s 
 the_lesions to_topical agent (imiquimod) and_to radiotherapy;2)_the_ease to_visually_monitor local response_and to perform_Fine Needle Aspiration biopsies_for mechanistic studies._A_Phase I/II trial will be conducted to evaluate the safety of the combination of_RT_and IMQ,_topically_applied_to skin metastases